$26.16
2.17%
Nasdaq, Nov 06, 04:00 pm EST. Closed.

Supernus Pharmaceuticals, Inc. Dividend history 11 years

Powered by StocksGuide
Register now for free to see the dividend history & estimates. Unlock now

Dividend Analysis of the Supernus Pharmaceuticals, Inc. Stock

Current dividend yield 9.39 %
Dividendenrendite 5 Jahre 4.3 %
Dividend Yield 10Y 5.37 %
Payout 3Y 5.16 %

When does Supernus Pharmaceuticals, Inc. pay a dividend?

Year Dividend Ex-day &
Payday
Frequency
Fiscal Year Dividend per Share Ex-Day Payday Payment frequency
2026
$8.13
$8.13
Nov 03 2026
Nov 03 2026
Nov 06 2026
Nov 03 26
Nov 06 26
Nov 06 2026
Special dividend
Special div.
2016
$0.3686
$0.37
Jun 16 2016
Jun 16 2016
Jul 29 2016
Jun 16 16
Jul 29 16
Jul 29 2016
semi annual
semi-annual
2015
$0.1241
$0.12
Sep 17 2015
Sep 17 2015
Oct 23 2015
Sep 17 15
Oct 23 15
Oct 23 2015
-
-

How much dividend does Supernus Pharmaceuticals, Inc. pay?

Supernus Pharmaceuticals, Inc. most recently paid a dividend of $8.13. Supernus Pharmaceuticals, Inc. paid a Dividend of $0.00 Per Share in the financial year 2025. With a stock price of $26.16 at Nov 06 2026, the current dividend yield is 0.00% (calculation: $0.00 / $26.16 = 0.00%). No special dividend was paid.

Use the StocksGuide screener to find the stocks with the highest dividend yields. Here you will find, for example, the 100 largest dividend stocks in the world:

What is the Supernus Pharmaceuticals, Inc. Dividend Yield and payout ratio?

The average Supernus Pharmaceuticals, Inc. dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.31%.

The payout ratio of Supernus Pharmaceuticals, Inc. in relation to the last financial year is 0.00%. The payout ratio smoothed over 3 years is 0.00%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).

Metric Supernus Pharmaceuticals, Inc.
Current dividend yield 0.00%
Dividend Yield 5Y 0.00%
Dividend Yield 10Y 0.31%
Payout 1Y 0.00%
Payout 3Y 0.00%

Is the Supernus Pharmaceuticals, Inc. dividend safe? Continuity & Dividend Growth

Is the Supernus Pharmaceuticals, Inc. dividend safe?

Supernus Pharmaceuticals, Inc. has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.

The average for the last 10 years is -100.00%.

Metric Supernus Pharmaceuticals, Inc.
Increased 0 Years
Continuity 0 Years
Paid 0 Years
Growth 10Y -100.00%

Continuity

Supernus Pharmaceuticals, Inc. has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.

Dividend Growth

The average for the last 10 years is -100.00%.

With the Stock Screener, you can search for the best Dividend Aristocrats in indices such as the DAX or NASDAQ.

Supernus Pharmaceuticals, Inc. Stock Forecast 2026

On the stock exchange, the Supernus Pharmaceuticals, Inc. stock (ISIN: US8684591089) is not traded as a top scorer in November 2026 according to the dividend strategy.

The stock price of Supernus Pharmaceuticals, Inc. -6.03% has fallen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Supernus Pharmaceuticals, Inc. stock price in real time at the top of the page.

Supernus Pharmaceuticals, Inc. (symbol: SUPN) is valued at a Price / Earnings Ratio (P/E ratio) of -13.84 and a price/sales ratio (P/S ratio) of 6.54 valued. Based on analyst estimates, the Supernus Pharmaceuticals, Inc. stock forecast 2026 of the current financial year corresponds to a valuation of 11.50 according to P/E ratio and 6.18 according to P/S.

Metric Supernus Pharmaceuticals, Inc.
Dividend Score ??/15
Performance 2026
6.03%
P/E TTM -13.84
P/S TTM 6.54
P/E forward 11.50
P/S forward 6.18

Supernus Pharmaceuticals, Inc. (symbol: SUPN) is valued at a Price / Earnings Ratio (P/E ratio) of -13.84 and a price/sales ratio (P/S ratio) of 6.54 valued. Based on analyst estimates, the Supernus Pharmaceuticals, Inc. stock forecast 2026 of the current financial year corresponds to a valuation of 11.50 according to P/E ratio and 6.18 according to P/S.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today